Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm [ROMA] and risk of malignancy index [RMI] in the preoperative assessment of patients with adnexal mass
Oman Medical Journal. 2016; 31 (5): 336-344
em Inglês
| IMEMR
| ID: emr-182054
ABSTRACT
Objectives:
To evaluate the validity and compare the performance of cancer antigen-125 [CA-125], human epididymis protein 4 [HE4], the risk of malignancy index [RMI], and the risk of ovarian malignancy algorithm [ROMA] in the diagnosis of ovarian cancer in patients with ovarian lesions discovered during their preoperative work-up investigations
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Tipo de estudo:
Guia de Prática Clínica
Idioma:
Inglês
Revista:
Oman Med. J.
Ano de publicação:
2016
Similares
MEDLINE
...
LILACS
LIS